ArticleThe breast journal2020

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis.

Javier Cortes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.